Exicure, Inc. (XCUR) Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Exicure, Inc. on August 9, 2023, covering events occurring on August 3 and August 4, 2023. The Company is an emerging growth company incorporated in Delaware with its principal executive offices in Chicago, Illinois. Its common stock trades on The Nasdaq Stock Market LLC under the symbol "XCUR."
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and legal matters rather than financial performance.
Material Changes and Events
- Nasdaq Non-Compliance Notice: On August 4, 2023, the Company received a notice from Nasdaq stating it no longer complies with Listing Rule 5605(c)(2) regarding audit committee composition. The Audit Committee currently consists of only one independent director following the resignation of Mr. Cheolho Jo. Consequently, the Company is no longer eligible for the previously granted cure period ending May 3, 2024.
- License Agreement Dispute: On August 3, 2023, the Company received a letter from counsel for Northwestern University alleging a breach of their License Agreement (effective May 27, 2014) and Restated License Agreement (effective August 15, 2015). The allegations concern a lack of required development under the licenses covering SNA technology and nanoparticle-based therapeutics.
Outlook, Risks, and Management Commentary
Delisting Risk: The Company has 45 calendar days to submit a plan to Nasdaq to regain compliance with audit committee requirements. If the plan is not accepted, the Company may appeal to a Nasdaq Hearings Panel. Management is actively searching for qualified independent directors to fill the vacancy.
Legal Contingency: The Company is evaluating the allegations from Northwestern University and expects to engage in discussions regarding the matter. Management states that the outcome of these discussions cannot be determined at this time.
Key Facts for Investor Verification
- Verify the timeline for submitting a compliance plan to Nasdaq to avoid potential delisting.
- Monitor the progress of the Company's search for new independent directors to satisfy Rule 5605(c)(2).
- Track the status of discussions with Northwestern University regarding the alleged breach of the SNA technology license.
- Confirm whether the Company will appeal a potential rejection of its compliance plan by Nasdaq.